Literature DB >> 2863509

Side-effects induced by carbamazepine-10,11-epoxide.

P N Patsalos, T J Stephenson, S Krishna, A A Elyas, P T Lascelles, C M Wiles.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2863509     DOI： 10.1016/s0140-6736(85)90420-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  11 in total

Review 1.  Pharmacokinetic interactions between antiepileptic drugs. Clinical considerations.

Authors:  R Riva; F Albani; M Contin; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1996-12       Impact factor: 6.447

2.  Lack of enzyme induction with oxcarbazepine (600 mg daily) in healthy subjects.

Authors:  J G Larkin; P J McKee; G Forrest; G H Beastall; B K Park; J I Lowrie; P Lloyd; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 3.  Therapeutic drug monitoring of anticonvulsants. State of the art.

Authors:  I A Choonara; A Rane
Journal:  Clin Pharmacokinet       Date:  1990-04       Impact factor: 6.447

4.  A comparative pharmacokinetic study of conventional and chewable carbamazepine in epileptic patients.

Authors:  P N Patsalos
Journal:  Br J Clin Pharmacol       Date:  1990-05       Impact factor: 4.335

5.  Effect of sodium valproate on carbamazepine disposition and psychomotor profile in man.

Authors:  G J Macphee; J R Mitchell; L Wiseman; A R McLellan; B K Park; G T McInnes; M J Brodie
Journal:  Br J Clin Pharmacol       Date:  1988-01       Impact factor: 4.335

Review 6.  Oxcarbazepine. A review of its pharmacology and therapeutic potential in epilepsy, trigeminal neuralgia and affective disorders.

Authors:  S M Grant; D Faulds
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

7.  Controlled evaluation of a supplementary dose of carbamazepine on psychomotor function in epileptic patients.

Authors:  G J Macphee; E M McPhail; E Butler; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 8.  Newer antiepileptic drugs. Towards an improved risk-benefit ratio.

Authors:  P N Patsalos; J W Sander
Journal:  Drug Saf       Date:  1994-07       Impact factor: 5.606

9.  Concentration-effect relationships with carbamazepine and its epoxide on psychomotor and cognitive function in epileptic patients.

Authors:  R A Gillham; N Williams; K Wiedmann; E Butler; J G Larkin; M J Brodie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-07       Impact factor: 10.154

Review 10.  Antiepileptic drugs. A review of clinically significant drug interactions.

Authors:  P N Patsalos; J S Duncan
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.